Membrane androgen receptor activation triggers down-regulation of PI-3K/ Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Papadopoulou, Natalia ^a   Charalampopoulos, Ioannis ^a   Anagnostopoulou, Vasileia ^a   Konstantinidis, Georgios ^a   Föller, Michael ^b   Gravanis, Achilleas ^a   Alevizopoulos, Konstantinos ^c   Lang, Florian ^b   Stournaras, Christos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Medexis Biotech SA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN CONJUGATE; ANDROGEN RECEPTOR; CASPASE 3; CYTOCHALASIN B; F ACTIN; FAS LIGAND; G ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; RHO FACTOR; TESTOSTERONE; ANTINEOPLASTIC AGENT; BAD PROTEIN, HUMAN; SERUM ALBUMIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN; CELL STRAIN DU145; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; PROSTATE CANCER; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; DOWN-REGULATION; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; SERUM ALBUMIN; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 59049095926     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-88     Document Type: Article

References (46)

1. Heinlein CA Chang C Androgen receptor in prostate cancer Endocr Rev 2004, 25:276-308. 10.1210/er.2002-0032 15082523
2. Rahman F Christian HC Non-classical actions of testosterone: An update Trends Endocrinol Metab 2007, 18(10):371-378. 10.1016/j.tem.2007.09.004 17997105
3. Foradori CD Weiser MJ Handa RJ Non-genomic actions of androgens Front Neuroendocrinol 2008, 29(2):169-181. 18093638
4. Freeman MR Cinar B Lu ML Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer Trends Endocrinol Metab 2005, 16:273-279. 10.1016/j.tem.2005.06.002 16002302
5. Lieberherr M Grosse B Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein J Biol Chem 1994, 269:7217-7223. 8125934
6. Sun YH Gao X Tang YJ Xu CL Wang LH Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells J Androl 2006, 27:671-678. 10.2164/jandrol.106.000554 16728719
7. Kampa M Papakonstanti EA Hatzoglou A Stathopoulos EN Stournaras C Castanas E The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton Faseb J 2002, 16:1429-1431. 12205037
8. Papakonstanti EA Kampa M Castanas E Stournaras C A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors Mol Endocrinol 2003, 17:870-881. 10.1210/me.2002-0253 12554777
9. Benten WP Lieberherr M Stamm O Wrehlke C Guo Z Wunderlich F Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages Mol Biol Cell 1999, 10:3113-3123. 25566 10512854
10. Benten WP Lieberherr M Giese G Wrehlke C Stamm O Sekeris CE Mossmann H Wunderlich F Functional testosterone receptors in plasma membranes of T cells Faseb J 1999, 13:123-133. 9872937
11. Kampa M Nifli AP Charalampopoulos I Alexaki VI Theodoropoulos PA Stathopoulos EN Gravanis A Castanas E Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis Exp Cell Res 2005, 307:41-51. 10.1016/j.yexcr.2005.02.027 15922725
12. Kallergi G Agelaki S Markomanolaki H Georgoulias V Stournaras C Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells Cell Physiol Biochem 2007, 20:977-986. 10.1159/000110458 17982280
13. Hatzoglou A Kampa M Kogia C Charalampopoulos I Theodoropoulos PA Anezinis P Dambaki C Papakonstanti EA Stathopoulos EN Stournaras C Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo J Clin Endocrinol Metab 2005, 90:893-903. 10.1210/jc.2004-0801 15585562
14. Gatson JW Kaur P Singh M et al Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells Endocrinology 2006, 147:2028-2034. 10.1210/ en.2005-1395 16410299
15. Alexaki VI Charalampopoulos I Kampa M Nifli AP Hatzoglou A Gravanis A Castanas E Activation of membrane estrogen receptors induce pro-survival kinases J Steroid Biochem Mol Biol 2006, 98:97-110. 10.1016/ j.jsbmb.2005.08.017 16414261
16. Somjen D Kohen F Gayer B Kulik T Knoll E Stern N Role of putative membrane receptors in the effect of androgens on human vascular cell growth J Endocrinol 2004, 180:97-106. 10.1677/joe.0.1800097 14709148
17. Papadopoulou N Charalampopoulos I Alevizopoulos K Gravanis A Stournaras C Rho/ROCK/Actin signaling regualtes membrane androgen receptor induced apoptosis in prostate cancer cells Exp Cell Res 2008, 314:3162-3174. 10.1016/j.yexcr.2008.07.012 18694745
18. Kampa M Kogia C Theodoropoulos PA Anezinis P Charalampopoulos I Papakonstanti EA Stathopoulos EN Hatzoglou A Stournaras C Gravanis A Castanas E Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells Mol Cancer Ther 2006, 5:1342-1351. 10.1158/1535-7163.MCT-05-0527 16731768
19. Alimirah F Chen J Basrawala Z Xin H Choubey D DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation FEBS Lett 2006, 580:2294-2300. 10.1016/j.febslet.2006.03.041 16580667
20. Stone KR Mickey DD Wunderli H Mickey GH Paulson DF Isolation of a human prostate carcinoma cell line (DU 145) Int J Cancer 1978, 21:274-281. 10.1002/ijc.2910210305 631930
21. Mitchell S Abel P Ware M Stamp G Lalani E Phenotypic and genotypic characterization of commonly used human prostatic cell lines BJU Int 2000, 85(7):932-944. 10.1046/j.1464-410x.2000.00606.x 10792179
22. Papakonstanti EA Stournaras C Actin cytoskeleton architecture and signaling in osmosensing Methods Enzymol 2007, 428:227-240. 10.1016/ S0076-6879(07)28012-7 17875420
23. Cairns P Okami K Halachmi S Halachmi N Esteller M Herman JG Jen J Isaacs WB Bova GS Sidransky D Frequent inactivation of PTEN/MMAC1 in primary prostate cancer Cancer Res 1997, 57:4997-5000. 9371490
24. Pesche S Latil A Muzeau F Cussenot O Fournier G Longy M Eng C Lidereau R PTEN/MMAC1/TEP1 involvement in primary prostate cancers Oncogene 1998, 16:2879-2883. 10.1038/sj.onc.1202081 9671408
25. Feilotter HE Nagai MA Boag AH Eng C Mulligan LM Analysis of PTEN and the 10q23 region in primary prostate carcinomas Oncogene 1998, 16:1743-1748. 10.1038/sj.onc.1200205 9582022
26. Vivanco I Sawyers CL The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2002, 2:489-501. 10.1038/nrc839 12094235
27. Cardone MH Roy N Stennicke HR Salvesen GS Franke TF Stanbridge E Frisch S Reed JC Regulation of cell death protease caspase-9 by phosphorylation Science 1998, 282:1318-1321. 10.1126/science.282.5392.1318 9812896
28. Datta SR Dudek H Tao X Masters S Fu H Gotoh Y Greenberg ME Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 1997, 91:231-241. 10.1016/S0092-8674(00)80405-5 9346240
29. Alessi DR James SR Downes CP Holmes AB Gaffney PR Reese CB Cohen P Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr Biol 1997, 7:261-269. 10.1016/S0960-9822(06)00122-9 9094314
30. Stokoe D Stephens LR Copeland T Gaffney PR Reese CB Painter GF Holmes AB McCormick F Hawkins PT Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B Science 1997, 277:567-570. 10.1126/science.277.5325.567 9228007
31. Vanhaesebroeck B Alessi DR The PI3K-PDK1 connection: More than just a road to PKB Biochem J 2000, 346(Pt 3):561-576. 1220886 10698680 10.1042/ 0264-6021:3460561
32. Zha J Harada H Yang E Jockel J Korsmeyer SJ Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell 1996, 87:619-628. 10.1016/S0092-8674(00)81382-3 8929531
33. Hayden MS Ghosh S Signaling to NF-kappaB Genes Dev 2004, 18:2195-2224. 10.1101/gad.1228704 15371334
34. Chen ZJ Parent L Maniatis T Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity Cell 1996, 84:853-862. 10.1016/S0092-8674(00)81064-8 8601309
35. Hatakeyama S Kitagawa M Nakayama K Shirane M Matsumoto M Hattori K Higashi H Nakano H Okumura K Onoe K Good RA Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/ F-box protein FWD1 Proc Natl Acad Sci USA 1999, 96:3859-3863. 22385 10097128 10.1073/pnas.96.7.3859
36. Spencer E Jiang J Chen ZJ Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP Genes Dev 1999, 13:284-294. 316434 9990853 10.1101/gad.13.3.284
37. Ghosh S Karin M Missing pieces in the NF-kappaB puzzle Cell 2002, 109(Suppl):S81-96. 10.1016/S0092-8674(02)00703-1 11983155
38. Li Q Verma IM NF-kappaB regulation in the immune system Nat Rev Immunol 2002, 2:725-734. 10.1038/nri910 12360211
39. Rokhlin OW Bishop GA Hostager BS Waldschmidt TJ Sidorenko SP Pavloff N Kiefer MC Umansky SR Glover RA Cohen MB Fas-mediated apoptosis in human prostatic carcinoma cell lines Cancer Res 1997, 57(9):1758-68. 9135020
40. Caraglia M Marra M Leonetti C Meo G D'Alessandro AM Baldi A Santini D Tonini G Bertieri R Zupi G Budillon A Abbruzzese A R115777 (Zarnestra)/ Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and Bad phosphorylation J Cell Physiol 2007, 211:2 533-43. 10.1002/ jcp.20960 17192846
41. Papadopoulou N Papakonstanti E Kallergi G Alevizopoulos K Stournaras C Membrane androgen receptor activation in tumor cells: Molecular signaling and clinical impact IUBMB life 2008.
42. Gourlay CW Ayscough KR The actin cytoskeleton: A key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005, 6:583-589. 10.1038/ nrm1682 16072039
43. Franklin-Tong VE Gourlay CW A role for actin in regulating apoptosis/ programmed cell death: Evidence spanning yeast, plants and animals Biochem J 2008, 413(3):389-404. 10.1042/BJ20080320 18613816
44. Papakonstanti EA Stournaras C Cell responses regulated by early reorganization of actin cytoskeleton FEBS Lett 2008, 582:2120-2127. 10.1016/j.febslet.2008.02.064 18325339
45. Stathopoulos EN Dambaki C Kampa M Theodoropoulos PA Anezinis P Delakas D Delides GS Castanas E Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells BMC Clin Pathol 2003, 3:1. 149438 12588669 10.1186/1472-6890-3-1
46. Dambaki C Kogia C Kampa M Darivianaki K Nomikos M Anezinis P Theodoropoulos PA Castanas E Stathopoulos EN Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: Study in paraffin tissue sections BMC Cancer 2005, 5:148. 1318463 16293185 10.1186/1471-2407-5-148